Abstract
This paper explores how company models are used by US payers and determines how and when models can make an effective contribution to improving formulary decision making. Two surveys were conducted with payers who were registered in the AMCP eDossier System; October 2014 and March-April 2015. Insights were gathered on payers’ perceptions and use of industry-provided models.
| Original language | English |
|---|---|
| Pages (from-to) | 18-21 |
| Number of pages | 4 |
| Journal | Value & Outcomes Spotlight |
| Volume | 2 |
| Issue number | 2 |
| Publication status | Published - Mar 2016 |